SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-189431
Filing Date
2018-06-11
Accepted
2018-06-11 16:13:58
Documents
4
Group Members
ISAAC MANKELIAM RATCLIFFENEW LEAF BIOPHARMA OPPORTUNITIES II, L.P.NEW LEAF BPO ASSOCIATES II, L.P.NEW LEAF BPO MANAGEMENT II, L.L.C.NEW LEAF VENTURE ASSOCIATES III, L.P.NEW LEAF VENTURES III, L.P.RONALD M. HUNTVIJAY K. LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13D d603105dsc13d.htm SC 13D 201710
2 EX-99.A d603105dex99a.htm EX-99.A 12840
3 EX-99.B d603105dex99b.htm EX-99.B 2616
4 EX-99.C d603105dex99c.htm EX-99.C 22506
  Complete submission text file 0001193125-18-189431.txt   241759
Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Venture Management III, L.L.C. (Filed by) CIK: 0001625657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Subject) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90503 | Film No.: 18892128
SIC: 2834 Pharmaceutical Preparations